Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy

BACKGROUND: Since the ToGA trial, trastuzumab-based chemotherapy is the standard treatment for HER2 positive stage IV gastric cancer. However, it is not yet clear whether surgical resection after trastuzumab-based chemotherapy (conversion surgery) can improve survival of HER2 positive stage IV gastr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Surg Case Rep
Main Authors: Hayano, Koichi, Watanabe, Hiroki, Ryuzaki, Takahiro, Sawada, Naoto, Ohira, Gaku, Kano, Masayuki, Uesato, Masaya, Matsubara, Hisahiro
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7516002/
https://ncbi.nlm.nih.gov/pubmed/32970254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-020-00984-w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares